12:00 AM
 | 
Mar 16, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BVdU: Completed Phase II enrollment

SciClone completed enrollment of 153 patients in a double-blind, placebo-controlled, international Phase II trial comparing six cycles of RP101 plus gemcitabine vs. gemcitabine alone. RP101 has Orphan Drug...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >